Issue 11/2018
Content (7 Articles)
Leading Article
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Kevin P. Jensen, Elise E. DeVito, Sarah Yip, Kathleen M. Carroll, Mehmet Sofuoglu
Systematic Review
Ketamine for Refractory Status Epilepticus: A Systematic Review
Anna Rosati, Salvatore De Masi, Renzo Guerrini
Systematic Review
Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis
Andrew T. Olagunju, Scott R. Clark, Bernhard T. Baune
Review Article
From LBR-101 to Fremanezumab for Migraine
Marcelo E. Bigal, Alan M. Rapoport, Stephen D. Silberstein, Sarah Walter, Richard J. Hargreaves, Ernesto Aycardi
Open Access
Review Article
Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis
Stefanie Kuerten, Leila J. Jackson, Joel Kaye, Timothy L. Vollmer
Open Access
Original Research Article
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison
Original Research Article
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis
Dimitrios Papadopoulos, Dimos-Dimitrios D. Mitsikostas